Syndicated Research

dtw Research, Inc. offers a wide variety of syndicated reports ranging from promotional summaries (SnapShot) to syndicated primary research (Launch-Pad, Message View & Impact Assessment).


Use the links to the right or the search box above to explore our published research. To request information, click the star to add research to your cart then click Submit Request. Search on any of the following:

  • Trade Name
  • Therapeutic Category/Sub-Category
  • Indication
  • Active Ingredient
  • Manufacturer
  • Type of Research

5 Most Recent SnapShots

Acromegaly Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Somatuline Depot, Somavert, Signifor LAR, Sandostatin LAR Depot

Alzheimer's Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Alzheimer's Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Exelon Patch, Namenda, Aricept, Axona

Antidepressants Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for Each Month in 2014.

Featuring: Forfivo XL, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena

Antiobesity Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for the Antiobesity Market for Each Month in 2014

Featuring: Alli, Qsymia (Formerly Qnexa), Releana, Didrex, Suprenza, Tenuate Retard, Bontril, Belviq, Adipex-P

Antipsychotics Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Olanzapine Tablets, Invega, Abilify, Xeplion, Xeroquel, Zyprexa, Seroquel, Sycrest

5 Most Recent Studies

CD Promo Message View Syndicated Antipsychotic Study

Featuring: Seroquel XR, Saphris, Invega Sustenna, Fanapt

Fielded Start: 04-07-2010

Fielded End: 04-13-2010

Generic Oxycodone/Oxymorphone Syndicated Impact Study

Featuring: Oxycodone, Oxymorphone

Fielded Start: 02-28-2013

Fielded End: 03-01-2013

Nucynta ER Wave 2 - 1 Year After Launch Study

Featuring: Nucynta

Fielded Start: 09-28-2012

Fielded End: 10-09-2012

Restrictions of Opioids in Non-Cancer Pain

Featuring: Narcotic/Non-Narcotic Analgesics

Fielded Start: 08-20-2012

Fielded End: 08-23-2012

Gralise Launch Pad; A Pre-Launch Awareness Study

Featuring: Gralise

Fielded Start: 06-21-2011

Fielded End: 06-23-2011

All

Analgesics

AntiMigraine/Headache

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

Biologics for RA/DMARDS

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Biologics for Ankylosing Spondylitis and Axial Spondyloarthritis Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Ankylosing Spondylitis and Axial Spondyloarthritis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Enbrel, Humira, Remicade

Biologics for GI Indications Global Market 2013 Annual Report

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Tysabri, Cimzia, Humira, Remicade

Biologics for GI Indications Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Entyvio, Tysabri, Cimzia, Humira, Remicade

Biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Stelara, Enbrel, Humira, Remicade

Biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Cimzia, Stelara, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis Global Market 2014 Quarterly Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2012 Annual Report

Summary of Print Promotions for the Biologics for RA Market for 2012.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Market 2011 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for January - June and July - December of 2011.

Featuring: Simponi, Orencia, Rituxan, Cimzia, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Rayos, Simponi, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Otrexup, Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Chronic Lymphocytic Leukemia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Chronic Lymphocytic Leukemia Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that Ibrutinib and Obinutuzumab are Imbruvia and Gazyva, respectively.

Featuring: Obinutuzumab, Arzerra, Rituxan, Ibrutinib, Gazyva, Treanda, Imbruvica

Chronic Lymphocytic Leukemia Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Chronic Lymphocytic Leukemia Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Arzerra, Rituxan, Gazyva, Treanda, Imbruvica

Cimzia & Simponi Syndicated Study

Featuring: Simponi, Cimzia

Fielded Start: 07-01-2009

Fielded End: 08-11-2009

Immunosuppressants Market 2011 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2011.

Featuring: Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Immunosuppressants Market 2012 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2012.

Featuring: Hecoria, Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Non-Hodgkin's Lymphoma 2013 Semi-Annual and Quarterly SnapShot Reports

Summary of Print Promotions for the Non-Hodgkin's Lymphoma Market for January - June, Q3, and Q4 2013.* *Please note that Gazyva is the brand name for Obinutuzumab, but in these reports, Gazyva had not yet been approved.

Featuring: Zevalin, Obinutuzumab, Rituxan, Gazyva, Treanda

Non-Hodgkin's Lymphoma 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Non-Hodgkin's Lymphoma Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Zevalin, Zydelig, Rituxan, Gazyva, Treanda

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Gout

Gout Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Gout Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Colcrys, Uloric, Krystexxa

Gout Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Gout Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Colcrys, Uloric, Krystexxa

Gout Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Gout Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Colcrys, Uloric, Krystexxa

Gout Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Gout Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Colcrys, Uloric, Krystexxa

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Miscellaneous Analgesics

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Narcotic/Non-Narcotic Analgesics

Antidepressants Market 2013 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for September, October, November, and December of 2013.* *Please note that there were no new materials for Emsam in 2013.

Featuring: Forfivo XL, Cymbalta, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena, Emsam

Cymbalta for Musculoskeletal Pain CD Promo Message View Post-Launch Tracking Study

Featuring: Cymbalta

Fielded Start: 01-20-2011

Fielded End: 02-09-2011

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

FDA Withdrawal of Darvon Impact Assessment Study

Featuring: Darvon

Fielded Start: 12-10-2010

Fielded End: 12-17-2010

Generic Oxycodone/Oxymorphone Syndicated Impact Study

Featuring: Oxycodone, Oxymorphone

Fielded Start: 02-28-2013

Fielded End: 03-01-2013

Major Depressive Disorder Market 2010 Year in Review

Featuring: Cymbalta, Pristiq, Seroquel XR, Abilify, Effexor XR, Lexapro

Nucynta ER CD Promo Message View Syndicated Launch Study

Featuring: Nucynta ER

Fielded Start: 11-09-2011

Fielded End: 12-06-2011

Nucynta ER Wave 2 - 1 Year After Launch Study

Featuring: Nucynta

Fielded Start: 09-28-2012

Fielded End: 10-09-2012

Nucynta PMRD Syndicated Launch Study

Featuring: Nucynta

Fielded Start: 07-22-2009

Fielded End: 08-03-2009

Opioid Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Opioid Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Oxycontin, Embeda, Exalgo, Remoxy, Opana ER, Nucynta, Onsolis

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Restrictions of Opioids in Non-Cancer Pain

Featuring: Narcotic/Non-Narcotic Analgesics

Fielded Start: 08-20-2012

Fielded End: 08-23-2012

Vimovo CD Promo Message View Launch Study

Featuring: Vimovo

Fielded Start: 09-14-2010

Fielded End: 09-24-2010

Vimovo CD Promo Message View Launch Study (Wave 2)

Featuring: Vimovo

Fielded Start: 05-18-2011

Fielded End: 06-01-2011

Neuropathic Pain

Antidepressants Market 2013 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for September, October, November, and December of 2013.* *Please note that there were no new materials for Emsam in 2013.

Featuring: Forfivo XL, Cymbalta, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena, Emsam

Cymbalta for Musculoskeletal Pain CD Promo Message View Post-Launch Tracking Study

Featuring: Cymbalta

Fielded Start: 01-20-2011

Fielded End: 02-09-2011

Generic Oxycodone/Oxymorphone Syndicated Impact Study

Featuring: Oxycodone, Oxymorphone

Fielded Start: 02-28-2013

Fielded End: 03-01-2013

Gralise Launch Pad; A Pre-Launch Awareness Study

Featuring: Gralise

Fielded Start: 06-21-2011

Fielded End: 06-23-2011

Major Depressive Disorder Market 2010 Year in Review

Featuring: Cymbalta, Pristiq, Seroquel XR, Abilify, Effexor XR, Lexapro

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

NSAIDS/Cox Inhibitors

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

The Launch of Duexis; A CD Promo Message View Study

Featuring: Duexis

Fielded Start: 02-21-2012

Fielded End: 03-01-2012

Vimovo CD Promo Message View Launch Study

Featuring: Vimovo

Fielded Start: 09-14-2010

Fielded End: 09-24-2010

Vimovo CD Promo Message View Launch Study (Wave 2)

Featuring: Vimovo

Fielded Start: 05-18-2011

Fielded End: 06-01-2011

Anesthetics

Anesthesia (Local, General, Topical)

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

AntiMicrobials/AntiParasitics

AntiBiotics/AntiMicrobials/Antiparasitics

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

AntiFungals (Oral/Injectables)

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Antiretrovirals (AIDS)

Hepatitis C Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2013.* *Please note that there were no new materials received for Tivicay in 2013.

Featuring: Pegasys, Sovaldi, Incivek, Tivicay, Victrelis, Olysio

Hepatitis C Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Pegasys, Sovaldi, Incivek, Tivicay, Victrelis, Olysio

HIV Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the HIV Market for Q1, Q2, and Q3 2012.

Featuring: Epzicom, Selzentry, Atripla, Complera, Viread, Isentress, Truvada, Intelence, Prezista, Reyataz, Stribild

HIV Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the HIV Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Epzicom, Selzentry, Atripla, Complera, Viread, Isentress, Truvada, Intelence, Prezista, Reyataz, Stribild

HIV Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the HIV Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Epzicom, Selzentry, Atripla, Complera, Viread, Isentress, Truvada, Intelence, Prezista, Reyataz, Stribild

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

AntiVirals (Not Including AIDS Products)

Hepatitis C Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Pegasys, Incivek, Victrelis

Hepatitis C Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2013.* *Please note that there were no new materials received for Tivicay in 2013.

Featuring: Pegasys, Sovaldi, Incivek, Tivicay, Victrelis, Olysio

Hepatitis C Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Pegasys, Sovaldi, Incivek, Tivicay, Victrelis, Olysio

HIV Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the HIV Market for Q1, Q2, and Q3 2012.

Featuring: Epzicom, Selzentry, Atripla, Complera, Viread, Isentress, Truvada, Intelence, Prezista, Reyataz, Stribild

HIV Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the HIV Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Epzicom, Selzentry, Atripla, Complera, Viread, Isentress, Truvada, Intelence, Prezista, Reyataz, Stribild

HIV Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the HIV Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Epzicom, Selzentry, Atripla, Complera, Viread, Isentress, Truvada, Intelence, Prezista, Reyataz, Stribild

Incivek and Victrelis; A CD Promo Message View Study, Wave 2

Featuring: Incivek, Victrelis

Fielded Start: 07-10-2012

Fielded End: 07-29-2012

Olysio and Sovaldi; A CD Promo Message View Study

Featuring: Sovaldi, Olysio

Fielded Start: 01-21-2014

Fielded End: 01-27-2014

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

The Launches of Incivek and Victrelis; A CD Promo Message View Study

Featuring: Incivek, Victrelis

Fielded Start: 07-13-2011

Fielded End: 07-20-2011

Cardiovasculars

AntiAnginals

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiArrhythmics

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives ACE Inhibitors

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives Aldosterone Blockers

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives Alpha Blockers

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives ARB (Angiotensin II Receptor Antagonists)

Antihypertensives: ARB Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive ARB Market for Q1, Q2, Q3, and Q4 of 2012.* Please note that there were no new materials for Avalide and Avapro in 2012.

Featuring: Tribenzor, Diovan, Benicar, Diovan HCT, Exforge, Benicar HCT, Exforge HCT, Micardis HCT, Twynsta, Avalide, Bystolic, Micardis, Edarbi, Avapro, Edarbyclor

Antihypertensives: Combination Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive Combination Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Tribenzor, Exforge, Exforge HCT, Twynsta, Caduet, Azor

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

The FDA Review of Benicar and ARBs Impact Assessment Study

Featuring: Benicar

Fielded Start: 08-17-2010

Fielded End: 08-24-2010

Twynsta Post-Launch Study

Featuring: Twynsta

Fielded Start: 12-09-2009

Fielded End: 12-21-2009

AntiHypertensives Beta Blockers

Antihypertensives: ARB Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive ARB Market for Q1, Q2, Q3, and Q4 of 2012.* Please note that there were no new materials for Avalide and Avapro in 2012.

Featuring: Tribenzor, Diovan, Benicar, Diovan HCT, Exforge, Benicar HCT, Exforge HCT, Micardis HCT, Twynsta, Avalide, Bystolic, Micardis, Edarbi, Avapro, Edarbyclor

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

The Launch of Dutoprol; A CD Promo Message View Study

Featuring: Dutoprol

Fielded Start: 05-03-2012

Fielded End: 05-09-2012

AntiHypertensives CCB (Calcium Channel Blockers)

Antihypertensives: ARB Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive ARB Market for Q1, Q2, Q3, and Q4 of 2012.* Please note that there were no new materials for Avalide and Avapro in 2012.

Featuring: Tribenzor, Diovan, Benicar, Diovan HCT, Exforge, Benicar HCT, Exforge HCT, Micardis HCT, Twynsta, Avalide, Bystolic, Micardis, Edarbi, Avapro, Edarbyclor

Antihypertensives: Combination Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive Combination Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Tribenzor, Exforge, Exforge HCT, Twynsta, Caduet, Azor

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Twynsta Post-Launch Study

Featuring: Twynsta

Fielded Start: 12-09-2009

Fielded End: 12-21-2009

AntiHypertensives Centrally Acting

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives Combinations

Antihypertensives: ARB Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive ARB Market for Q1, Q2, Q3, and Q4 of 2012.* Please note that there were no new materials for Avalide and Avapro in 2012.

Featuring: Tribenzor, Diovan, Benicar, Diovan HCT, Exforge, Benicar HCT, Exforge HCT, Micardis HCT, Twynsta, Avalide, Bystolic, Micardis, Edarbi, Avapro, Edarbyclor

Antihypertensives: Combination Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive Combination Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Tribenzor, Exforge, Exforge HCT, Twynsta, Caduet, Azor

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Twynsta Post-Launch Study

Featuring: Twynsta

Fielded Start: 12-09-2009

Fielded End: 12-21-2009

AntiHypertensives PPH (Primary Pulmonary Hypertension)

Antihypertensives: PAH Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive PAH Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Revatio, Adcirca, Veletri, Tracleer, Letairis, Ventavis

Antihypertensives: PAH Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive PAH Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Revatio, Adcirca, Veletri, Tracleer, Letairis, Ventavis, Opsumit

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

AntiHypertensives Renin Inhibitors

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives Vasodilators

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

AntiHypertensives Vasopeptidase Inhibitors

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Cholesterol Lowering Agents

Antihypertensives: Combination Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive Combination Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Tribenzor, Exforge, Exforge HCT, Twynsta, Caduet, Azor

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Impact of the FDA Label Change for Simvastatin 80 mg, An Impact Assessment Study

Featuring: Simvastatin

Fielded Start: 07-06-2011

Fielded End: 07-08-2011

Loss of Exclusivity Marketing Strategies

Analysis on Brands' Marketing Strategies Before, During, and After Their Loss of Exclusivity

Featuring: Lipitor, Zyprexa

Non-Insulin Diabetes Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Januvia, Victoza, Actos, Byetta, Bydureon, Onglyza, Cycloset, Jentadueto, Tradjenta, Kombiglyze XR, Janumet, Janumet XR, Juvisync

Non-Insulin Diabetes Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Januvia, Victoza, Actos, Byetta, Kazano, Invokana, Bydureon, Onglyza, Jentadueto, Tradjenta, Kombiglyze XR, Oseni, Janumet, Nesina, Janumet XR, Juvisync

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

The Launch of Juvisync; A CD Promo Message View Launch Study

Featuring: Juvisync

Fielded Start: 11-16-2011

Fielded End: 11-29-2011

TriLipix Post-Launch Study

Featuring: TriLipix

Fielded Start: 02-19-2009

Fielded End: 02-26-2009

Cholesterol/Triglyceride Lowering Agents

Antihypertensives: Combination Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive Combination Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Tribenzor, Exforge, Exforge HCT, Twynsta, Caduet, Azor

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Impact of the FDA Label Change for Simvastatin 80 mg, An Impact Assessment Study

Featuring: Simvastatin

Fielded Start: 07-06-2011

Fielded End: 07-08-2011

Loss of Exclusivity Marketing Strategies

Analysis on Brands' Marketing Strategies Before, During, and After Their Loss of Exclusivity

Featuring: Lipitor, Zyprexa

Non-Insulin Diabetes Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Januvia, Victoza, Actos, Byetta, Bydureon, Onglyza, Cycloset, Jentadueto, Tradjenta, Kombiglyze XR, Janumet, Janumet XR, Juvisync

Non-Insulin Diabetes Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Januvia, Victoza, Actos, Byetta, Kazano, Invokana, Bydureon, Onglyza, Jentadueto, Tradjenta, Kombiglyze XR, Oseni, Janumet, Nesina, Janumet XR, Juvisync

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

The Launch of Juvisync; A CD Promo Message View Launch Study

Featuring: Juvisync

Fielded Start: 11-16-2011

Fielded End: 11-29-2011

TriLipix Post-Launch Study

Featuring: TriLipix

Fielded Start: 02-19-2009

Fielded End: 02-26-2009

Congestive Heart Failure/Inotropics

Antihypertensives: ARB Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive ARB Market for Q1, Q2, Q3, and Q4 of 2012.* Please note that there were no new materials for Avalide and Avapro in 2012.

Featuring: Tribenzor, Diovan, Benicar, Diovan HCT, Exforge, Benicar HCT, Exforge HCT, Micardis HCT, Twynsta, Avalide, Bystolic, Micardis, Edarbi, Avapro, Edarbyclor

Hyponatremia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hyponatremia Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Samsca

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Diuretics

Antihypertensives: ARB Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive ARB Market for Q1, Q2, Q3, and Q4 of 2012.* Please note that there were no new materials for Avalide and Avapro in 2012.

Featuring: Tribenzor, Diovan, Benicar, Diovan HCT, Exforge, Benicar HCT, Exforge HCT, Micardis HCT, Twynsta, Avalide, Bystolic, Micardis, Edarbi, Avapro, Edarbyclor

Antihypertensives: Combination Therapies Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive Combination Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Tribenzor, Exforge, Exforge HCT, Twynsta, Caduet, Azor

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

The Launch of Dutoprol; A CD Promo Message View Study

Featuring: Dutoprol

Fielded Start: 05-03-2012

Fielded End: 05-09-2012

Miscellaneous Cardiovasculars

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Stroke/AntiCoagulants

Antithrombotics/Anticoagulants Global Market 2010 Annual SnapShot Report

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for 2010.

Featuring: Effient, Plavix

Antithrombotics/Anticoagulants Global Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for Q1, Q2, Q3, and Q4 of 2011.

Featuring: Effient, Brilinta, Brilique, DuoPlavin, Pradaxa, Pradax, Efient, Plavix

Antithrombotics/Anticoagulants Global Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Effient, Eliquis, Xarelto, Brilinta, Brilique, DuoPlavin, Pradaxa, Pradax, Efient, Plavix

Antithrombotics/Anticoagulants Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Effient, Eliquis, Xarelto, Brilinta, Brilique, DuoPlavin, Pradaxa, Pradax, Efient, Plavix

Antithrombotics/Anticoagulants Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Effient, Eliquis, Xarelto, Brilinta, Brilique, DuoPlavin, Pradaxa, Pradax, Efient, Plavix

Antithrombotics/Anticoagulants Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for Q1, Q2, Q3, and Q4 of 2011.

Featuring: Effient, Xarelto, Pradaxa, Plavix

Antithrombotics/Anticoagulants Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulants Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Effient, Xarelto, Brilinta, Pradaxa, Plavix

Antithrombotics/Anticoagulants Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics/Anticoagulant Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Effient, Eliquis, Xarelto, Brilinta, Pradaxa, Plavix

Antithrombotics/Anticoagulants Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotic/Anticoagulant Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Effient, Eliquis, Xarelto, Brilinta, Pradaxa, Zontivity

Antithrombotics Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Eliquis, Xarelto, Pradaxa

Antithrombotics Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Eliquis, Xarelto, Pradaxa

Antithrombotics Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Eliquis, Xarelto, Pradaxa

Antithrombotics Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antithrombotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Eliquis, Xarelto, Pradaxa

Antithrombotics Market 6-Month Retrospective Review

Featuring: Effient, Pradaxa, Plavix

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Patient Assistance Programs; PCP and Cardiology Perspectives

Featuring: Cardiovasculars

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Central Nervous System

ADHD

ADHD Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the ADHD Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Kapvay, Focalin XR, Concerta, Daytrana, Strattera, Vyvanse, Intuniv, Adderall XR, Quillivant XR

ADHD Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the ADHD Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that there were no new materials received for Concerta in 2013.

Featuring: Kapvay, Focalin XR, Concerta, Daytrana, Strattera, Vyvanse, Intuniv, Adderall XR, Quillivant XR

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Alcohol/Drug Dependence

Opioid Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Opioid Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Oxycontin, Embeda, Exalgo, Remoxy, Opana ER, Nucynta, Onsolis

Alzheimer/Dementia

Alzheimer's Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Alzheimer's Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Exelon Patch, Namenda, Aricept

Alzheimer's Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Alzheimer's Market for Q3 and Q4 of 2013.* *Please note that there were no new materials for Aricept in 2013.

Featuring: Exelon Patch, Namenda, Aricept, Axona

Alzheimer's Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Alzheimer's Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Exelon Patch, Namenda, Aricept, Axona

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

AntiConvulsants

Anticonvulsants Market 2012 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Anticonvulsants Market for January - June and July to December of 2012.

Featuring: Banzel Oral Suspension, Potiga, Onfi, Banzel Tablets, Sabril, Vimpat

Anticonvulsants Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Anticonvulsants Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that there we no new materials for Topamax in 2013.

Featuring: Banzel Oral Suspension, Potiga, Onfi, Oxtellar XR, Trokendi XR, Banzel Tablets, Sabril, Vimpat, Keppra, Aptiom (Formerly Stedesa)

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

AntiDepressants/AntiAnxiety

Antidepressants Market 2013 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for September, October, November, and December of 2013.* *Please note that there were no new materials for Emsam in 2013.

Featuring: Forfivo XL, Cymbalta, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena, Emsam

Antidepressants Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for Each Month in 2014.

Featuring: Forfivo XL, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena

Antipsychotics Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that there were no new materials received for Zyprexa in 2013

Featuring: Zypadhera, Invega, Abilify, Xeplion, Xeroquel, Zyprexa, Seroquel, Risperidone Tablets USP, Sycrest

Antipsychotics Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Olanzapine Tablets, Invega, Abilify, Xeplion, Xeroquel, Zyprexa, Seroquel, Sycrest

Antipsychotics Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Zyprexa Relprevv, Geodon, Seroquel XR, Abilify, Saphris, Zyprexa, Risperdal Consta, Invega Sustenna, Latuda, Fanapt, Symbyax

Antipsychotics Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that there were no new materials for Fanapt or Symbyax in 2013.

Featuring: Zyprexa Relprevv, Adasuve, Geodon, Invega, Seroquel XR, Abilify, Saphris, Zyprexa, Risperdal Consta, Abilify Maintena, Invega Sustenna, Latuda, Fanapt, Symbyax

Antipsychotics Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Adasuve, Seroquel XR, Abilify, Saphris, Risperdal, Abilify Maintena, Invega Sustenna, Latuda, Fanapt

CD Promo Message View Syndicated Antipsychotic Study

Featuring: Seroquel XR, Saphris, Invega Sustenna, Fanapt

Fielded Start: 04-07-2010

Fielded End: 04-13-2010

Cymbalta for Musculoskeletal Pain CD Promo Message View Post-Launch Tracking Study

Featuring: Cymbalta

Fielded Start: 01-20-2011

Fielded End: 02-09-2011

Major Depressive Disorder Market 2010 Year in Review

Featuring: Cymbalta, Pristiq, Seroquel XR, Abilify, Effexor XR, Lexapro

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

AntiObesity/AnoRexiants/CNS Stimulants

Antiobesity Market 2013 Semi-Annual and Monthly SnapShot Reports

Summary of Print Promotions for the Antiobesity Market for January - June and July, August, September, October, November, and December of 2013.* Please note that there were no new materials for Alli, Bontril, Didrex, Releana, or Tenuate in 2013.

Featuring: Alli, Qsymia (Formerly Qnexa), Releana, Didrex, Suprenza, Tenuate Retard, Bontril, Belviq, Adipex-P

Antiobesity Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for the Antiobesity Market for Each Month in 2014

Featuring: Alli, Qsymia (Formerly Qnexa), Releana, Didrex, Suprenza, Tenuate Retard, Bontril, Belviq, Adipex-P

AntiPsychotic/AntiManic

Antidepressants Market 2013 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for September, October, November, and December of 2013.* *Please note that there were no new materials for Emsam in 2013.

Featuring: Forfivo XL, Cymbalta, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena, Emsam

Antidepressants Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for Each Month in 2014.

Featuring: Forfivo XL, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena

Antipsychotics Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that there were no new materials received for Zyprexa in 2013

Featuring: Zypadhera, Invega, Abilify, Xeplion, Xeroquel, Zyprexa, Seroquel, Risperidone Tablets USP, Sycrest

Antipsychotics Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Olanzapine Tablets, Invega, Abilify, Xeplion, Xeroquel, Zyprexa, Seroquel, Sycrest

Antipsychotics Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Zyprexa Relprevv, Geodon, Seroquel XR, Abilify, Saphris, Zyprexa, Risperdal Consta, Invega Sustenna, Latuda, Fanapt, Symbyax

Antipsychotics Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that there were no new materials for Fanapt or Symbyax in 2013.

Featuring: Zyprexa Relprevv, Adasuve, Geodon, Invega, Seroquel XR, Abilify, Saphris, Zyprexa, Risperdal Consta, Abilify Maintena, Invega Sustenna, Latuda, Fanapt, Symbyax

Antipsychotics Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Antipsychotics Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Adasuve, Seroquel XR, Abilify, Saphris, Risperdal, Abilify Maintena, Invega Sustenna, Latuda, Fanapt

CD Promo Message View Syndicated Antipsychotic Study

Featuring: Seroquel XR, Saphris, Invega Sustenna, Fanapt

Fielded Start: 04-07-2010

Fielded End: 04-13-2010

Latuda CD Promo Message View Post-Launch Tracking Study

Featuring: Latuda

Fielded Start: 03-08-2011

Fielded End: 03-10-2011

Loss of Exclusivity Marketing Strategies

Analysis on Brands' Marketing Strategies Before, During, and After Their Loss of Exclusivity

Featuring: Lipitor, Zyprexa

Major Depressive Disorder Market 2010 Year in Review

Featuring: Cymbalta, Pristiq, Seroquel XR, Abilify, Effexor XR, Lexapro

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Saphris Launch-PAD Study

Featuring: Saphris

Fielded Start: 09-17-2009

Fielded End: 09-18-2009

Neurologics (I.E., MS, ALS)

Biologics for GI Indications Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Tysabri, Cimzia, Humira, Remicade

Biologics for GI Indications Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Entyvio, Tysabri, Cimzia, Humira, Remicade

Gilenya CD Promo Message View Post-Launch Tracking Study

Featuring: Gilenya

Fielded Start: 11-02-2010

Fielded End: 11-17-2010

Gilenya CD Promo Message View Post-Launch Tracking Study (Wave 2)

Featuring: Gilenya

Fielded Start: 10-12-2011

Fielded End: 12-07-2011

Gilenya Launch-Pad Pre-Launch Awareness Study

Featuring: Gilenya

Fielded Start: 09-16-2010

Fielded End: 09-29-2010

Multiple Sclerosis Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Extavia, Betaseron, Tysabri, Gilenya, Rebif, Copaxone, Avonex

Multiple Sclerosis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Extavia, Betaseron, Tysabri, Gilenya, Aubagio, Rebif, Copaxone, Avonex

Multiple Sclerosis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Extavia, Betaseron, Tecfidera, Tysabri, Gilenya, Aubagio, Rebif, Rebif Rebidose, Copaxone, Avonex

Multiple Sclerosis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Extavia, Betaseron, Tecfidera, Tysabri, Gilenya, Aubagio, Rebif, Plegridy, Rebif Rebidose, Copaxone, Avonex

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Patient Assistance Programs; The Neurologist Perspective

Featuring: Neurologics (I.E., MS, ALS)

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Sedatives/Hypnotics/Sleep Disorders

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Dermatologics

Acne/Rosacea

Oral Contraceptives Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Oral Contraceptives Market for 2013.

Featuring: Lybrel, Minastrin 24 Fe, Yaz, Ortho Evra, Safyral, Ella, Seasonique, Loestrin, Generess Fe, Ortho Tri-Cyclen Lo, Beyaz, Natazia, Quartette

Oral Contraceptives Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Contraceptives Market for Q1 and Q2 of 2014.

Featuring: Lybrel, Minastrin 24 Fe, Yaz, Ortho Evra, Safyral, Ella, Seasonique, Loestrin, Generess Fe, Ortho Tri-Cyclen Lo, Beyaz, Natazia, Quartette

Cosmetics

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Dermatitis/AntiPruritics/Dry Skin (Inc. Soaps)

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Eczema/Psoriasis

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Biologics for Ankylosing Spondylitis and Axial Spondyloarthritis Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Ankylosing Spondylitis and Axial Spondyloarthritis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Enbrel, Humira, Remicade

Biologics for GI Indications Global Market 2013 Annual Report

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Tysabri, Cimzia, Humira, Remicade

Biologics for GI Indications Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Entyvio, Tysabri, Cimzia, Humira, Remicade

Biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Stelara, Enbrel, Humira, Remicade

Biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Cimzia, Stelara, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis Global Market 2014 Quarterly Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2012 Annual Report

Summary of Print Promotions for the Biologics for RA Market for 2012.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Market 2011 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for January - June and July - December of 2011.

Featuring: Simponi, Orencia, Rituxan, Cimzia, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Rayos, Simponi, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Otrexup, Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Immunosuppressants Market 2011 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2011.

Featuring: Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Immunosuppressants Market 2012 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2012.

Featuring: Hecoria, Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Miscellaneous Dermatologics

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Menopause Market 2012 Quarterly SnapShot Report

Summary of Print Promotions for the Menopause Market for Q4 2012.

Featuring: Divigel, Vivelle-Dot, Minivelle, Vagifem, Angeliq, Estring, Enjuvia, Premarin, EstroGel

Menopause Market 2013 Quarterly SnapShot Report

Summary of Print Promotions for the Menopause Market for Q1 and Q2 2013.

Featuring: Divigel, Elestrin, Vagifem, Minivelle, Angeliq, CombiPatch, Estring, Osphena, Enjuvia, Premarin, Brisdelle, EstroGel

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Photodamage/Depigmenting Agents

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Topical Analgesics

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Topical Steroids/AntiInfectives/AntiFungals

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Gastrointestinals

AntiDiarrheals/Laxatives

Acromegaly Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Somatuline Depot, Somavert, Sandostatin LAR Depot

Acromegaly Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Somatuline Depot, Somavert, Signifor LAR, Sandostatin LAR Depot

Biologics for GI Indications Global Market 2013 Annual Report

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Constella, Humira, Remicade

Non-Biologics for IBD/IBS Market 2013 Quarterly and Monthly SnapShot Reports

Summary of Print Promotions for Non-Biologics for IBD and IBS for Q1, Q2, July, August, September, October, November, and December of 2013.

Featuring: Lotronex, Linzess, Amitiza, Donnatal Elixir

Non-Biologics for IBD/IBS Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for Non-Biologics for IBD and IBS for each month of 2014.

Featuring: Lotronex, Linzess, Amitiza, Donnatal Elixir

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

IBD/IBS/Ulcerative Colitis/Crohn's Disease

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Biologics for Ankylosing Spondylitis and Axial Spondyloarthritis Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Ankylosing Spondylitis and Axial Spondyloarthritis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Enbrel, Humira, Remicade

Biologics for GI Indications Global Market 2013 Annual Report

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Constella, Humira, Remicade

Biologics for GI Indications Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Tysabri, Cimzia, Humira, Remicade

Biologics for GI Indications Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for Ulcerative Colitis, Crohn's Disease, and IBD for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Entyvio, Tysabri, Cimzia, Humira, Remicade

Biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Stelara, Enbrel, Humira, Remicade

Biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Cimzia, Stelara, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis Global Market 2014 Quarterly Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2012 Annual Report

Summary of Print Promotions for the Biologics for RA Market for 2012.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Orencia, Cimzia, Enbrel, Humira, RoActemra, Remicade

Biologics for Rheumatoid Arthritis Market 2011 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for January - June and July - December of 2011.

Featuring: Simponi, Orencia, Rituxan, Cimzia, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Rayos, Simponi, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Otrexup, Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Cimzia & Simponi Syndicated Study

Featuring: Simponi, Cimzia

Fielded Start: 07-01-2009

Fielded End: 08-11-2009

Multiple Sclerosis Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Extavia, Betaseron, Tysabri, Gilenya, Rebif, Copaxone, Avonex

Multiple Sclerosis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Extavia, Betaseron, Tysabri, Gilenya, Aubagio, Rebif, Copaxone, Avonex

Multiple Sclerosis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Extavia, Betaseron, Tecfidera, Tysabri, Gilenya, Aubagio, Rebif, Rebif Rebidose, Copaxone, Avonex

Multiple Sclerosis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Extavia, Betaseron, Tecfidera, Tysabri, Gilenya, Aubagio, Rebif, Plegridy, Rebif Rebidose, Copaxone, Avonex

Non-Biologics for IBD/IBS Market 2013 Quarterly and Monthly SnapShot Reports

Summary of Print Promotions for Non-Biologics for IBD and IBS for Q1, Q2, July, August, September, October, November, and December of 2013.

Featuring: Lotronex, Linzess, Amitiza, Donnatal Elixir

Non-Biologics for IBD/IBS Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for Non-Biologics for IBD and IBS for each month of 2014.

Featuring: Lotronex, Linzess, Amitiza, Donnatal Elixir

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Incontinence/AntiSpasmodics/AntiCholinergics

Antidepressants Market 2013 Monthly SnapShot Reports

Summary of Print Promotions for the Antidepressants Market for September, October, November, and December of 2013.* *Please note that there were no new materials for Emsam in 2013.

Featuring: Forfivo XL, Cymbalta, Brintellix, Pristiq, Seroquel XR, Abilify, Viibryd, Wellbutrin XL, Fetzima, Abilify Maintena, Emsam

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cymbalta for Musculoskeletal Pain CD Promo Message View Post-Launch Tracking Study

Featuring: Cymbalta

Fielded Start: 01-20-2011

Fielded End: 02-09-2011

Major Depressive Disorder Market 2010 Year in Review

Featuring: Cymbalta, Pristiq, Seroquel XR, Abilify, Effexor XR, Lexapro

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Peptic Ulcer Disease/GERD/Antacids

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

The Launch of Duexis; A CD Promo Message View Study

Featuring: Duexis

Fielded Start: 02-21-2012

Fielded End: 03-01-2012

Vimovo CD Promo Message View Launch Study

Featuring: Vimovo

Fielded Start: 09-14-2010

Fielded End: 09-24-2010

Vimovo CD Promo Message View Launch Study (Wave 2)

Featuring: Vimovo

Fielded Start: 05-18-2011

Fielded End: 06-01-2011

Hormones

Blood Modifiers/Hematologic Agents

Hemophilia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hemophilia Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Eloctate, Helixate FS, Alprolix, Humate-P, NovoSeven, Turoctocog Alfa, Kogenate, Monoclate-P, Xyntha, Rixubis, Mononine, BeneFix, Koate-DVI, Advate

Hemophilia Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Hemophilia Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Eloctate, Helixate FS, Alprolix, Berinin P, Humate-P, NovoSeven, Turoctocog Alfa, Kogenate, NovoEight, Xyntha, Monoclate-P, Rixubis, NovoThirteen, Mononine, BeneFix, Koate-DVI, Advate

Immunoglobulin/Albumin Market 2013 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Immunoglobulin/Albumin Market for January - June and July - December of 2013.* Please note that there were no new materials received for Flebogamma DIF in 2013.

Featuring: Privigen, Gamunex-C, Octagam, Flebogamma DIF, Hizentra, Gammagard

Immunoglobulin/Albumin Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Immunoglobulin/Albumin Market for Q1, Q2, Q3, Q4 2014.

Featuring: Privigen, Gamunex-C, Octagam, Flebogamma DIF, Hizentra, Gammagard

Multiple Myeloma Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Multiple Myeloma Market for 2013.

Featuring: Velcade, Pomalyst, Revlimid, Kyprolis

Multiple Myeloma Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Myeloma Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Zometa, Velcade, Pomalyst, Revlimid, Kyprolis

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

BPH

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Contraceptives (All Forms)

Insertable/Implantable Contraceptives Market 2013 SnapShot Annual Report

Summary of Print Promotions for the Insertable/Implantable Contraceptives Market for 2013.

Featuring: Nexplanon, Nuvaring, Skyla, Ortho Evra, Implanon, Mirena, Essure, Paragard T 380A Intrauterine Copper Contraceptive

Insertable/Implantable Contraceptives Market 2014 SnapShot Quarterly Reports

Summary of Print Promotions for the Insertable/Implantable Contraceptives Market for Q1 and Q2 of 2014.

Featuring: Nexplanon, Nuvaring, Skyla, Ortho Evra, Implanon, Levosert, Mirena, Essure, Paragard T 380A Intrauterine Copper Contraceptive

Oral Contraceptives Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Oral Contraceptives Market for 2013.

Featuring: Lybrel, Minastrin 24 Fe, Yaz, Ortho Evra, Safyral, Ella, Seasonique, Loestrin, Generess Fe, Ortho Tri-Cyclen Lo, Beyaz, Natazia, Quartette

Oral Contraceptives Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Contraceptives Market for Q1 and Q2 of 2014.

Featuring: Lybrel, Minastrin 24 Fe, Yaz, Ortho Evra, Safyral, Ella, Seasonique, Loestrin, Generess Fe, Ortho Tri-Cyclen Lo, Beyaz, Natazia, Quartette

Diabetes (Injectable/Inhaled)

Diabetes Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Diabetes Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Tresiba, Victoza, Januvia, Xigduo, Vildagliptin/Metformin, Byetta, Invokana, Bydureon, Onglyza, Efficib, Forxiga, Jentadueto, Eucreas, Icandra, Vipidia, Xiliarx, Kombiglyze XR, Zomarist, Tesavel, Oseni, Nesina, Janumet, Velmetia, Vildagliptin, Trajenta, Galvus, Vipdomet, Xelevia, Jalra, Ristaben, Lantus, Lyxumia, Ristfor, Farxiga

Insulin Diabetes Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Insulin/Injectable Diabetes Market for Q1, Q2, Q3, and Q4 of 2011.

Featuring: NovoLog, Levemir, Humalog, Apidra, Lantus

Insulin Diabetes Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Insulin/Injectable Diabetes Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: NovoLog, Levemir, Humalog, Apidra, Lantus

Insulin Diabetes Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Insulin/Insertable Diabetes Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that there were no new pieces received for Afrezza in 2013.

Featuring: Tresiba, NovoLog, Levemir, Humalog, Apidra, Lantus, Afrezza

Insulin Diabetes Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Insulin/Injectable Diabetes Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Tresiba, NovoLog, Levemir, Humalog, Apidra, Lantus, Afrezza

Non-Insulin Diabetes Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Januvia, Victoza, Actos, Byetta, Onglyza, Cycloset, Kombiglyze XR, Janumet, Avandia

Non-Insulin Diabetes Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Januvia, Victoza, Actos, Byetta, Bydureon, Onglyza, Cycloset, Jentadueto, Tradjenta, Kombiglyze XR, Janumet, Janumet XR, Juvisync

Non-Insulin Diabetes Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Januvia, Victoza, Actos, Byetta, Kazano, Invokana, Bydureon, Onglyza, Jentadueto, Tradjenta, Kombiglyze XR, Oseni, Janumet, Nesina, Janumet XR, Juvisync

Non-Insulin Diabetes Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Tresiba, Januvia, Victoza, Byetta, Actos, Duetact, Kazano, Invokana, Bydureon, Onglyza, ACTOplus Met, Jardiance, Jentadueto, Tradjenta, Kombiglyze XR, Oseni, Janumet, Nesina, Janumet XR, Farxiga

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Risk of Pancreatic Cancer and/or Pancreatitis Associated with Byetta and/or Januvia; An Impact Assessment Study

Featuring: Januvia, Byetta

Fielded Start: 11-10-2011

Fielded End: 11-16-2011

The Launch of Afrezza; A Launch-Pad Study

Featuring: Afrezza

Fielded Start: 01-15-2013

Fielded End: 01-16-2013

Victoza CD Promo Message View Post-Launch Study

Featuring: Victoza

Fielded Start: 03-02-2010

Fielded End: 03-03-2010

Diabetes (Oral)

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Diabetes Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Diabetes Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Tresiba, Victoza, Januvia, Xigduo, Vildagliptin/Metformin, Byetta, Invokana, Bydureon, Onglyza, Efficib, Forxiga, Jentadueto, Eucreas, Icandra, Vipidia, Xiliarx, Kombiglyze XR, Zomarist, Tesavel, Oseni, Nesina, Janumet, Velmetia, Vildagliptin, Trajenta, Galvus, Vipdomet, Xelevia, Jalra, Ristaben, Lantus, Lyxumia, Ristfor, Farxiga

Januvia Syndicated Study

Featuring: Januvia

Fielded Start: 05-20-2009

Fielded End: 05-28-2009

Non-Insulin Diabetes Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Januvia, Victoza, Actos, Byetta, Onglyza, Cycloset, Kombiglyze XR, Janumet, Avandia

Non-Insulin Diabetes Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Januvia, Victoza, Actos, Byetta, Bydureon, Onglyza, Cycloset, Jentadueto, Tradjenta, Kombiglyze XR, Janumet, Janumet XR, Juvisync

Non-Insulin Diabetes Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Januvia, Victoza, Actos, Byetta, Kazano, Invokana, Bydureon, Onglyza, Jentadueto, Tradjenta, Kombiglyze XR, Oseni, Janumet, Nesina, Janumet XR, Juvisync

Non-Insulin Diabetes Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Oral Diabetes Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Tresiba, Januvia, Victoza, Byetta, Actos, Duetact, Kazano, Invokana, Bydureon, Onglyza, ACTOplus Met, Jardiance, Jentadueto, Tradjenta, Kombiglyze XR, Oseni, Janumet, Nesina, Janumet XR, Farxiga

Onglyza Syndicated Study

Featuring: Onglyza

Fielded Start: 09-11-2009

Fielded End: 09-14-2009

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Risk of Pancreatic Cancer and/or Pancreatitis Associated with Byetta and/or Januvia; An Impact Assessment Study

Featuring: Januvia, Byetta

Fielded Start: 11-10-2011

Fielded End: 11-16-2011

The Launch of Juvisync; A CD Promo Message View Launch Study

Featuring: Juvisync

Fielded Start: 11-16-2011

Fielded End: 11-29-2011

Victoza CD Promo Message View Post-Launch Study

Featuring: Victoza

Fielded Start: 03-02-2010

Fielded End: 03-03-2010

Glucose Monitors/Insulin Pumps/Syringes

Glucose Monitor Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Glucose Monitors Market for Q1, Q2, Q3, and Q4 2011.* *Please note, this report is organized by corporation instead of by brand due to the high number of brands included.

Featuring: Bayer, Roche, Abbott, Glucose Monitors/Insulin Pumps/Syringes, LifeScan

Glucose Monitor Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Glucose Monitors Market for Q1, Q2, Q3, and Q4 2012.* *Please note, this report is organized by corporation instead of by brand due to the high number of brands included.

Featuring: Bayer, Roche, Abbott, Glucose Monitors/Insulin Pumps/Syringes, LifeScan

Glucose Monitor Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Glucose Monitors Market for Q1, Q2, Q3, and Q4 2013.* *Please note, this report is organized by corporation instead of by brand due to the high number of brands included.

Featuring: Bayer, Roche, Abbott, Glucose Monitors/Insulin Pumps/Syringes, LifeScan

Growth Failure Therapies

Acromegaly Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Somatuline Depot, Somavert, Sandostatin LAR Depot

Acromegaly Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Somatuline Depot, Somavert, Signifor LAR, Sandostatin LAR Depot

Male Hormone Replacement Therapy (HRT)

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Menopause/ERT/HRT (Female)

Menopause Market 2012 Quarterly SnapShot Report

Summary of Print Promotions for the Menopause Market for Q4 2012.

Featuring: Divigel, Vivelle-Dot, Minivelle, Vagifem, Angeliq, Estring, Enjuvia, Premarin, EstroGel

Menopause Market 2013 Quarterly SnapShot Report

Summary of Print Promotions for the Menopause Market for Q1 and Q2 2013.

Featuring: Divigel, Elestrin, Vagifem, Minivelle, Angeliq, CombiPatch, Estring, Osphena, Enjuvia, Premarin, Brisdelle, EstroGel

Miscellaneous Hormones

Antiobesity Market 2013 Semi-Annual and Monthly SnapShot Reports

Summary of Print Promotions for the Antiobesity Market for January - June and July, August, September, October, November, and December of 2013.* Please note that there were no new materials for Alli, Bontril, Didrex, Releana, or Tenuate in 2013.

Featuring: Alli, Qsymia (Formerly Qnexa), Releana, Didrex, Suprenza, Tenuate Retard, Bontril, Belviq, Adipex-P

Antiobesity Market 2014 Monthly SnapShot Reports

Summary of Print Promotions for the Antiobesity Market for Each Month in 2014

Featuring: Alli, Qsymia (Formerly Qnexa), Releana, Didrex, Suprenza, Tenuate Retard, Bontril, Belviq, Adipex-P

Osteoporosis

Multiple Myeloma Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Myeloma Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Zometa, Velcade, Pomalyst, Revlimid, Kyprolis

Osteoporosis Global Market 2011 Annual SnapShot Report

Summary of Print Promotions for the Osteoporosis Market for 2011.

Featuring: Acrel, Optinate, Aclasta, Prolia, Bonviva, Evista, Protelos, Osseor, Forteo, Forsteo, Actonel

Osteoporosis Global Market 2012 Annual SnapShot Report

Summary of Print Promotions for the Osteoporosis Market from September 2011 - September 2012.

Featuring: Acrel, Optinate, Boniva, Aclasta, Prolia, Evista, Protelos, Osseor, Forteo, Forsteo, Actonel

Osteoporosis Global Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Osteoporosis Market from September 2012 - September 2013.

Featuring: Acrel, Optinate, Aclasta, Prolia, Bonviva, Evista, Protelos, Osseor, Forteo, Forsteo, Actonel

Osteoporosis Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Boniva, Atelvia, Prolia, Evista, Reclast, Forteo, Actonel

Osteoporosis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Boniva, Atelvia, Prolia, Evista, Reclast, Forteo, Actonel

Osteoporosis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2013.* *Please note that there were no new pieces received for Actonel in 2013.

Featuring: Boniva, Atelvia, Prolia, Evista, Reclast, Forteo, Binosto, Actonel

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Reclast E-Recall Study - FREE

Featuring: Reclast

Fielded Start: 02-20-2009

Fielded End: 02-23-2009

Immunomodulators/Immune Modifiers

Immunomodulators/Immune Modifiers

Antihypertensives: PAH Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive PAH Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Revatio, Adcirca, Veletri, Tracleer, Letairis, Ventavis, Opsumit

Hepatitis C Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Pegasys, Incivek, Victrelis

Hepatitis C Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2013.* *Please note that there were no new materials received for Tivicay in 2013.

Featuring: Pegasys, Sovaldi, Incivek, Tivicay, Victrelis, Olysio

Hepatitis C Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Hepatitis C Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Pegasys, Sovaldi, Incivek, Tivicay, Victrelis, Olysio

Immunoglobulin/Albumin Market 2013 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Immunoglobulin/Albumin Market for January - June and July - December of 2013.* Please note that there were no new materials received for Flebogamma DIF in 2013.

Featuring: Privigen, Gamunex-C, Octagam, Flebogamma DIF, Hizentra, Gammagard

Immunoglobulin/Albumin Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Immunoglobulin/Albumin Market for Q1, Q2, Q3, Q4 2014.

Featuring: Privigen, Gamunex-C, Octagam, Flebogamma DIF, Hizentra, Gammagard

Immunosuppressants Market 2011 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2011.

Featuring: Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Immunosuppressants Market 2012 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2012.

Featuring: Hecoria, Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Incivek and Victrelis; A CD Promo Message View Study, Wave 2

Featuring: Incivek, Victrelis

Fielded Start: 07-10-2012

Fielded End: 07-29-2012

Melanoma 2012 Quarterly SnapShot Reports

Featuring: Zelboraf, Sylatron For Injection, Yervoy

Multiple Myeloma Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Multiple Myeloma Market for 2013.

Featuring: Velcade, Pomalyst, Revlimid, Kyprolis

Multiple Myeloma Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Myeloma Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Zometa, Velcade, Pomalyst, Revlimid, Kyprolis

Multiple Sclerosis Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Extavia, Betaseron, Tysabri, Gilenya, Rebif, Copaxone, Avonex

Multiple Sclerosis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Extavia, Betaseron, Tysabri, Gilenya, Aubagio, Rebif, Copaxone, Avonex

Multiple Sclerosis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Extavia, Betaseron, Tecfidera, Tysabri, Gilenya, Aubagio, Rebif, Rebif Rebidose, Copaxone, Avonex

Multiple Sclerosis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Sclerosis Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Extavia, Betaseron, Tecfidera, Tysabri, Gilenya, Aubagio, Rebif, Plegridy, Rebif Rebidose, Copaxone, Avonex

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

The Launches of Incivek and Victrelis; A CD Promo Message View Study

Featuring: Incivek, Victrelis

Fielded Start: 07-13-2011

Fielded End: 07-20-2011

Immunosuppressants

Immunosuppressants

Biologics and Non-biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.* Please note that no new pieces were received for Dovonex, Luxiq, Olux, and Temovate for 2013.

Featuring: Apremilast, Taclonex, Vanos Cream, Olux, Nizoral, Vectical Ointment, Stelara, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Biologics for Psoriasis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Stelara, Enbrel, Humira, Remicade

Biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Stelara, Otezla, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Cimzia, Stelara, Enbrel, Humira, Remicade

Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics for Psoriatic Arthritis and Ankylosing Spondylitis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Simponi, Cimzia, Stelara, Otezla, Enbrel, Humira, Remicade

Immunosuppressants Market 2011 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2011.

Featuring: Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Immunosuppressants Market 2012 Semi-Annual Reports

Summary of Print Promotions for the Immunosuppressants Market for January - June and July - December 2012.

Featuring: Hecoria, Myfortic, CellCept, Zortress, Rapamune, Nulojix, Prograf, Neoral

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Miscellaneous

Miscellaneous

Hemophilia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hemophilia Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Eloctate, Helixate FS, Alprolix, Humate-P, NovoSeven, Turoctocog Alfa, Kogenate, Monoclate-P, Xyntha, Rixubis, Mononine, BeneFix, Koate-DVI, Advate

Hemophilia Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Hemophilia Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Eloctate, Helixate FS, Alprolix, Berinin P, Humate-P, NovoSeven, Turoctocog Alfa, Kogenate, NovoEight, Xyntha, Monoclate-P, Rixubis, NovoThirteen, Mononine, BeneFix, Koate-DVI, Advate

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Orphan

Antihypertensives: PAH Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Antihypertensive PAH Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Revatio, Adcirca, Veletri, Tracleer, Letairis, Ventavis, Opsumit

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Neuromuscular

AntiParkinsons/Extrapyramidal Disorders/Restless Legs Syndrome

Generic Oxycodone/Oxymorphone Syndicated Impact Study

Featuring: Oxycodone, Oxymorphone

Fielded Start: 02-28-2013

Fielded End: 03-01-2013

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Miscellaneous Neuromuscular

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Skeletal Muscle Relaxants/Hyperactivity

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Nutritionals

Nutritional, Enteral/Parenteral/Oral, Vitamins (Rx and OTC)

Cholesterol Lowering Agent Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Caduet, Lipitor, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Cholesterol Lowering Agent Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Cholesterol Lowering Agents Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Crestor, Vytorin, Zetia, Niaspan, Liptruzet, Livalo, Juxtapid, TriLipix, Welchol, Kynamro, Lipitor, Caduet, TriCor, Vascepa, Lovaza, Simcor, Lescol XL

Hyponatremia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Hyponatremia Market for Q1, Q2, Q3, and Q4 2013.

Featuring: Samsca

Oncologics/AntiNeoplastics

Oncologics/AntiNeoplastics

Acromegaly Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Somatuline Depot, Somavert, Sandostatin LAR Depot

Acromegaly Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Acromegaly Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Somatuline Depot, Somavert, Signifor LAR, Sandostatin LAR Depot

Biologics and Non-biologics for Psoriasis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for Biologics and Non-biologics for Psoriasis Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Apremilast, Temovate E, Taclonex, Vanos Cream, Methotrexate, Olux, Nizoral, Vectical Ointment, Stelara, Otezla, Enbrel, Humira, Luxiq, Clobex, Dovonex, Remicade, Temovate Gel, Temovate Cream, Cyclosporine, Acitretin Capsules

Biologics for Rheumatoid Arthritis Market 2011 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for January - June and July - December of 2011.

Featuring: Simponi, Orencia, Rituxan, Cimzia, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Rayos, Simponi, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Biologics for Rheumatoid Arthritis Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Biologics for RA Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Otrexup, Rayos, Simponi, Simponi ARIA, Orencia, Rituxan, Cimzia, Xeljanz, Enbrel, Humira, Remicade, Actemra

Chronic Lymphocytic Leukemia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Chronic Lymphocytic Leukemia Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that Ibrutinib and Obinutuzumab are Imbruvia and Gazyva, respectively.

Featuring: Obinutuzumab, Arzerra, Rituxan, Ibrutinib, Gazyva, Treanda, Imbruvica

Chronic Lymphocytic Leukemia Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Chronic Lymphocytic Leukemia Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Arzerra, Rituxan, Gazyva, Treanda, Imbruvica

Lung Cancer 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Lung Cancer Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Tivantinib, Erbitux, Gilotrif, Gemzar, Xalkori, Alimta, Avastin, Tarceva, Abraxane, Vargatef

Lung Cancer 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Lung Cancer Market for Q1, Q2, Q3, and Q4 2013.* *Please note that there were no new pieces received for Inlyta in 2013.

Featuring: Erbitux, Gilotrif, Inlyta, Gemzar, Xalkori, Alimta, Avastin, Tarceva, Abraxane

Melanoma 2012 Quarterly SnapShot Reports

Featuring: Zelboraf, Sylatron For Injection, Yervoy

Multiple Myeloma Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Multiple Myeloma Market for 2013.

Featuring: Velcade, Pomalyst, Revlimid, Kyprolis

Multiple Myeloma Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Multiple Myeloma Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Zometa, Velcade, Pomalyst, Revlimid, Kyprolis

Non-Hodgkin's Lymphoma 2013 Semi-Annual and Quarterly SnapShot Reports

Summary of Print Promotions for the Non-Hodgkin's Lymphoma Market for January - June, Q3, and Q4 2013.* *Please note that Gazyva is the brand name for Obinutuzumab, but in these reports, Gazyva had not yet been approved.

Featuring: Zevalin, Obinutuzumab, Rituxan, Gazyva, Treanda

Non-Hodgkin's Lymphoma 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Non-Hodgkin's Lymphoma Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Zevalin, Zydelig, Rituxan, Gazyva, Treanda

Non-Small Cell Lung Cancer Global Market 2013 Semi-Annual SnapShot Report

Summary of Print Promotions for the Non-Small Cell Lung Cancer Market for July - December 2013.

Featuring: Tivantinib, Erbitux, Gilotrif, Gemzar, Xalkori, Alimta, Avastin, Tarceva, Zykadia

Non-Small Cell Lung Cancer Global Market 2014 Quarterly SnapShot Report

Summary of Print Promotions for the Non-Small Cell Lung Cancer Market for Q1, Q2, Q3, and Q4 2014.

Featuring: Tivantinib, Erbitux, Gilotrif, Gemzar, Xalkori, Alimta, Avastin, Tarceva, Zykadia

Osteoporosis Global Market 2011 Annual SnapShot Report

Summary of Print Promotions for the Osteoporosis Market for 2011.

Featuring: Acrel, Optinate, Aclasta, Prolia, Bonviva, Evista, Protelos, Osseor, Forteo, Forsteo, Actonel

Osteoporosis Global Market 2012 Annual SnapShot Report

Summary of Print Promotions for the Osteoporosis Market from September 2011 - September 2012.

Featuring: Acrel, Optinate, Boniva, Aclasta, Prolia, Evista, Protelos, Osseor, Forteo, Forsteo, Actonel

Osteoporosis Global Market 2013 Annual SnapShot Report

Summary of Print Promotions for the Osteoporosis Market from September 2012 - September 2013.

Featuring: Acrel, Optinate, Aclasta, Prolia, Bonviva, Evista, Protelos, Osseor, Forteo, Forsteo, Actonel

Osteoporosis Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Boniva, Atelvia, Prolia, Evista, Reclast, Forteo, Actonel

Osteoporosis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2012.

Featuring: Boniva, Atelvia, Prolia, Evista, Reclast, Forteo, Actonel

Osteoporosis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2013.* *Please note that there were no new pieces received for Actonel in 2013.

Featuring: Boniva, Atelvia, Prolia, Evista, Reclast, Forteo, Binosto, Actonel

Patient Access & Assistance Programs SnapShot

An Analysis of Brand and Corporate Patient Assistance Programs Across Multiple Therapy Areas.

Featuring: Bayer, Januvia, Victoza, Genentech, AstraZeneca, Xarelto, Tasigna, Apriso, Atripla, Betaseron, Simponi, Brilinta, Invokana, Janssen, Vertex, Biogen Idec, Abilify, Dificid, Pegasys, Incivek, Tradjenta, Xyntha, Amitiza, Prolia, Gilenya, Benlysta, Sandostatin, Prezista, Salix Pharmaceuticals, Sabril, Nuvigil, Axiron, Rebif, Daytrana, Pfizer, Cimzia, Merck, Xeljanz, Sprycel, Vimpat, Nulojix, Nexavar, Janumet, Amgen, Zytiga, Bosulif, Enbrel, Invega Sustenna, Kaletra, Humira, Takeda, Bristol-Myers Squibb, Nucynta, Xgeva, Fanapt, Novartis, Remicade, Apidra, Xtandi, Xifaxan, Tercica, Inc., A Subsidiary Of The Ipsen Group, Actemra, Lunesta, Rozerem, Afinitor, Provenge, Exelon Patch, Zelboraf

Patient Assistance Programs; PCP and ENDO Perspectives

Featuring: Oncologics/AntiNeoplastics

Fielded Start: 05-10-2011

Fielded End: 05-20-2011

Patient Assistance Programs: Perspectives from Oncologists, Oncology Nurses and Oncology Office Staff 2012

Featuring: Oncologics/AntiNeoplastics

Fielded Start: 02-27-2012

Fielded End: 04-23-2012

Patient Assistance Programs: Perspectives from Oncologists, Oncology Nurses and Oncology Office Staff 2013

Featuring: Oncologics/AntiNeoplastics

Fielded Start: 11-01-2013

Fielded End: 11-01-2013

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

The Launches of Yervoy and Zelboraf

Featuring: Zelboraf, Yervoy

Fielded Start: 11-16-2011

Fielded End: 01-30-2012

The Launch of Imbruvica; A CD Promo Message View Study

Featuring: Imbruvica

The Launch of Provenge; A CD Promo Message View Post-Launch Tracking Study

Featuring: Provenge

Fielded Start: 04-15-2011

Fielded End: 05-31-2011

The Launch of Zaltrap; A CD Promo Message View Study

Featuring: Zaltrap

Yervoy and Zelboraf; A CD Promo Message View Study, Wave 2

Featuring: Zelboraf, Yervoy

Fielded Start: 12-01-2012

Fielded End: 12-19-2012

Ophthalmologics

Miscellaneous Ophthalmologics

Cervical Dystonia Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Botox, Dysport, Myobloc, Xeomin

Cervical Dystonia Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Cervical Dystonia Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Botox, Dysport, Myobloc, Xeomin

Respiratory/Allergy

Allergic Rhinitis/Pruritus (Oral/Inhaled/Ophth.)

Allergic Rhinitis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Allergic Rhinitis Market for Q1, Q2, Q3, and Q4 of 2013.* *Please note that there were no new materials for Veramyst in 2013.

Featuring: Patanase Nasal Spray, Nasonex, Astepro, Dymista, Zetonna, Omnaris, QNASL

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

Anaphylaxis

Anaphylaxis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Anaphylaxis Market for Q4 of 2012.

Featuring: EpiPen, Auvi-Q

Anaphylaxis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Anaphylaxis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: EpiPen, Auvi-Q

Bronchodilators/AntiAsthmatics/COPD (Oral/Inhaled)

Anaphylaxis Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Anaphylaxis Market for Q4 of 2012.

Featuring: EpiPen, Auvi-Q

Anaphylaxis Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Anaphylaxis Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: EpiPen, Auvi-Q

COPD Global Market 2013 Quarterly SnapShot Report

Summary of Print Promotions for the COPD Market for Q1, Q2, Q3, and Q4 of 2013.

Featuring: Spiriva, Symbicort, Eklira Genuair, Daxas, Seebri, Bretaris Genuair, Viani

COPD Global Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the COPD Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Relvar Ellipta, Spiriva, Ultibro Breezhaler, Seretide, Symbicort, Eklira Genuair, Daxas, Striverdi Respimat, Seebri, Anoro Ellipta, Bretaris Genuair, Viani

COPD Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the COPD Market for Q1, Q2, Q3, and Q4 of 2012.

Featuring: Advair Diskus, Foradil, Arcapta Neohaler, Spiriva, Symbicort, Perforomist, Daliresp, Dulera, Combivent, Brovana Inhalation Solution

COPD Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the COPD Market for Q1, Q2, and Q4 of 2013.* *Please note that there were no new materials received for Foradil in 2013.

Featuring: Advair Diskus, Foradil, Arcapta Neohaler, Spiriva, Symbicort, Tudorza Pressair, Perforomist, Breo Ellipta, Daliresp, Dulera, Combivent, Brovana Inhalation Solution

COPD Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the COPD Market for Q1, Q2, Q3, and Q4 of 2014.

Featuring: Advair Diskus, Arcapta Neohaler, Spiriva, Incruse Ellipta, Symbicort, Tudorza Pressair, Perforomist, Tudorza Genuair, Breo Ellipta, Daliresp, Striverdi Respimat, Combivent, Brovana Inhalation Solution, Anoro Ellipta

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Cough Cold/AntiTussives/Expectorants

FDA Advisory Recommendations For Acetaminophen Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 07-17-2009

Fielded End: 07-28-2009

FDA Review of Acetaminophen Dosing Impact Assessment Study

Featuring: Acetaminophen

Fielded Start: 02-07-2011

Fielded End: 02-08-2011

Miscellaneous Respiratory/Allergy

Promotion of Drugs Indication for Orphan Diseases SnapShot

Summary of Pre- and Post-Launch Print Promotions for Products Indicated for Orphan Diseases.

Featuring: Afinitor, Banzel Oral Suspension, Sylatron For Injection, Ilaris, Cinryze, Istodax, Onfi, Jakafi, Cayston, Firazyr, Soliris, Banzel Tablets, Xalkori, Avastin, Sabril, Arzerra, Rituxan, Adcirca, Xenazine, Qutenza, Nulojix, Krystexxa, Treanda, Gralise, Tyvaso Inhaled, Kalbitor, Elelyso For Injection, Kyprolis, Kalydeco, Xiaflex, Ampyra

Sexual Dysfunction

Erectile/Sexual Dysfunction

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Vaccines/Allergy Extracts

Vaccines/Allergy Extracts

Immunoglobulin/Albumin Market 2013 Semi-Annual SnapShot Reports

Summary of Print Promotions for the Immunoglobulin/Albumin Market for January - June and July - December of 2013.* Please note that there were no new materials received for Flebogamma DIF in 2013.

Featuring: Privigen, Gamunex-C, Octagam, Flebogamma DIF, Hizentra, Gammagard

Immunoglobulin/Albumin Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Immunoglobulin/Albumin Market for Q1, Q2, Q3, Q4 2014.

Featuring: Privigen, Gamunex-C, Octagam, Flebogamma DIF, Hizentra, Gammagard

Pre-Launch Unbranded Communication Strategies & Tactics SnapShot Volume 1

An Analysis of The Promotional Strategies and Tactics of Brands as They Move from Pre-, During, and Post-Launch.

Featuring: Cymbalta, Crestor, Zetia, Januvia, Zelboraf, Cialis, Spiriva, Tasigna, Namenda, Atripla, Byetta, Lantus SoloSTAR, Nexium, Seroquel XR, Provigil, Abilify, Requip, Incivek, Prolia, Gilenya, Avastin, Levitra, Lexapro, Aranesp, Pradaxa, Janumet, Zytiga, Yervoy, Gardasil, Enbrel, Humira, Victrelis, Remicade, Vyvanse, Lantus, Lunesta

Vaccines Market 2011 Quarterly SnapShot Reports

Summary of Print Promotions for the Vaccines Market for Q1, Q2, Q3, and Q4 2011.

Featuring: Menactra, Rotarix, Pneumovax 23, Cervarix, Menveo, Gardasil, Rotateq, Prevnar 13

Vaccines Market 2012 Quarterly SnapShot Reports

Summary of Print Promotions for the Vaccines Market for Q1, Q2, Q3, and Q4 2012.* *Please note, this report is organized by corporation instead of by brand due to the high number of brands included.

Featuring: GlaxoSmithKline, Vaccines/Allergy Extracts, Pfizer, Merck, Sanofi Pasteur, Novartis

Vaccines Market 2013 Quarterly SnapShot Reports

Summary of Print Promotions for the Osteoporosis Market for Q1, Q2, Q3, and Q4 2013.* *Please note, this report is organized by corporation instead of by brand due to the high number of brands included.

Featuring: GlaxoSmithKline, Vaccines/Allergy Extracts, Pfizer, Merck, Sanofi Pasteur, Novartis

Vaccines Market 2014 Quarterly SnapShot Reports

Summary of Print Promotions for the Vaccines Market for Q1, Q2, Q3, and Q4 2014.* *Please note, this report is organized by corporation instead of by brand due to the high number of brands included.

Featuring: GlaxoSmithKline, Vaccines/Allergy Extracts, Pfizer, Merck, Sanofi Pasteur, Novartis

X

Contact our sales department:

*
*
*
*

Is your company currently a CD Promo WorldWide subscriber? *



* denotes a required field.

Submit Request

Your request has been successfully submitted to our sales staff!

Expect someone to contact you within the next several business days.


© 2014 dtw Research, Inc. All Rights Reserved.
Privacy Policy | Terms of Use | Mobile Site